» Articles » PMID: 10656679

Bcl-2 and Bax Regulate the Channel Activity of the Mitochondrial Adenine Nucleotide Translocator

Overview
Journal Oncogene
Date 2000 Feb 3
PMID 10656679
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Bcl-2 family protein including anti-apoptotic (Bcl-2) or pro-apoptotic (Bax) members can form ion channels when incorporated into synthetic lipid bilayers. This contrasts with the observation that Bcl-2 stabilizes the mitochondrial membrane barrier function and inhibits the permeability transition pore complex (PTPC). Here we provide experimental data which may explain this apparent paradox. Bax and adenine nucleotide translocator (ANT), the most abundant inner mitochondrial membrane protein, can interact in artificial lipid bilayers to yield an efficient composite channel whose electrophysiological properties differ quantitatively and qualitatively from the channels formed by Bax or ANT alone. The formation of this composite channel can be observed in conditions in which Bax protein alone has no detectable channel activity. Cooperative channel formation by Bax and ANT is stimulated by the ANT ligand atractyloside (Atr) but inhibited by ATP, indicating that it depends on the conformation of ANT. In contrast to the combination of Bax and ANT, ANT does not form active channels when incorporated into membranes with Bcl-2. Rather, ANT and Bcl-2 exhibit mutual inhibition of channel formation. Bcl-2 prevents channel formation by Atr-treated ANT and neutralizes the cooperation between Bax and ANT. Our data are compatible with a ménage à trois model of mitochondrial apoptosis regulation in which ANT, the likely pore forming protein within the PTPC, interacts with Bax or Bcl-2 which influence its pore forming potential in opposing manners.

Citing Articles

RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential.

Ning Y, Zheng M, Zhang Y, Jiao Y, Wang J, Zhang S Cancer Cell Int. 2024; 24(1):339.

PMID: 39402585 PMC: 11475559. DOI: 10.1186/s12935-024-03519-7.


Orexins in apoptosis: a dual regulatory role.

Cavalu S, Saber S, Hamad R, Abdel-Reheim M, Elmorsy E, Youssef M Front Cell Neurosci. 2024; 18:1336145.

PMID: 38699177 PMC: 11064656. DOI: 10.3389/fncel.2024.1336145.


Ferroptosis: A new insight for treatment of acute kidney injury.

Li S, Wang R, Wang Y, Liu Y, Qiao Y, Li P Front Pharmacol. 2022; 13:1065867.

PMID: 36467031 PMC: 9714487. DOI: 10.3389/fphar.2022.1065867.


An Update to Hallmarks of Cancer.

Ravi S, Alencar Jr A, Arakelyan J, Xu W, Stauber R, Wang C Cureus. 2022; 14(5):e24803.

PMID: 35686268 PMC: 9169686. DOI: 10.7759/cureus.24803.


Role of reactive oxygen species in tumors based on the 'seed and soil' theory: A complex interaction (Review).

Liang W, He X, Bi J, Hu T, Sun Y Oncol Rep. 2021; 46(3).

PMID: 34328200 PMC: 8329912. DOI: 10.3892/or.2021.8159.